EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›FC

FC

FRANKLIN COVEY CO

Next earnings Jul 1, 2026 · consensus $0.27 EPS, $70.4M rev

Last earnings +2.3% on 2026-04-01

Sell
$24.84
▲ +4.72%
$24.84▲ +10.06%
over 1Y
L $11.54EODHDH $24.84
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.7%
1W+6.4%
1M+3.8%
3M+62.5%
YTD+49.3%
1Y+10.1%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Sell
Quality
D
Valuation
Overvalued
Filings
Clean
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 11 analysts
Buy

Revenue declined -7.0% YoY.

Revenue (FY2025) $267M · FY2025

The read

Weak on both the fundamentals and the price — little to like at the current level.

FRANKLIN COVEY CO shows $267M in FY2025 revenue (-7.0% YoY), a 1.1% net margin, and 4.6% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$224M$263M$281M$287M$267M
Gross profit$173M$202M$213M$221M$204M
Operating income$8.10M$23.7M$26.4M$33.0M$5.70M
Net income$13.6M$18.4M$17.8M$23.4M$3.07M
Diluted EPS$0.96$1.27$1.24$1.74$0.24
Net margin6.1%7.0%6.3%8.1%1.1%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$291M
EV / EBITDA17.2
EV / Sales1.1
EV / FCF14.0
P / FCF14.6
PEG (trailing)—
Earnings yield1.0%
FCF yield6.9%

Quality & risk

ROIC (est.)5.1%
Free cash flow$20.7M
Total debt$20.9M
Net cash$10.8M
Altman Z-Score2.80 grey
Piotroski F-Score6/9

Capital returns

Buyback yield8.7%
Dividend yield (est.)—
Shareholder yield8.7%
Shares Δ YoY-7.8%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Routine disclosure cadence — no material red flags in recent filings.
  1. 8-K Other event2026-06-17
  2. 10-Q Quarterly report2026-04-08
  3. 8-K Earnings results2026-04-01
  4. 8-K Other event2026-03-18
  5. 8-K Shareholder vote2026-01-23
  6. 10-Q Quarterly report2026-01-09
  7. 8-K Earnings results2026-01-07
  8. 8-K Other event2025-12-22
  9. DEF 14A Proxy statement2025-12-18

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-172026-06-17open ↗4Period ending 2026-06-032026-06-04open ↗SCHEDULE 13GFiling2026-05-15open ↗SCHEDULE 13GFiling2026-04-22open ↗10-QPeriod ending 2026-02-282026-04-08open ↗4Period ending 2026-04-072026-04-08open ↗8-KPeriod ending 2026-04-012026-04-01open ↗SCHEDULE 13G/AFiling2026-03-26open ↗8-KPeriod ending 2026-03-182026-03-18open ↗SCHEDULE 13G/AFiling2026-02-17open ↗4Period ending 2026-01-292026-01-30open ↗4Period ending 2026-01-232026-01-27open ↗

Quality score

D
ValueGrowthProfitHealthMom.
ValueC-
GrowthF
ProfitabilityC-
Financial healthB-
Momentum—
  • ✗Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✗Liabilities below 2× equity
  • ✗P/E below 25

Fair value est.

$1.57

Overvalued -94% vs price

cheapfair valueexpensive

Modified Graham: EPS $0.24 × (8.5 + 1.5 × 0.0% growth) × 0.77 quality = 6.5× multiple. An estimate, not a price target.

Revenue
$267M
-7.0% YoY
Net margin
1.1%
ROE
4.6%
P/E
103.5

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$267M-7.0%
Net income$3.07M-86.9%
Gross profit$204M-7.9%
Operating income$5.70M-82.7%
Diluted EPS$0.24-86.2%
Cash & equivalents$31.7M-34.9%
Total assets$243M-7.1%
Total liabilities$176M-1.3%
Stockholders' equity$66.9M-19.5%
Gross: 76.2%Op.: 2.1%L/E: 2.63x

Frequently asked

Is FRANKLIN COVEY CO (FC) a buy?
FC currently carries a Sell rating with 3/5 conviction, derived from its latest SEC filings. Revenue declined -7.0% YoY.
What is FC's fair value?
A Modified-Graham model based on FC's SEC fundamentals estimates a fair value of about $1.57. It is an estimate from reported earnings, not a price target.
Is FC overvalued or undervalued?
Against a Modified-Graham fair-value estimate, FC currently appears overvalued relative to its SEC-grounded earnings power.
What is FRANKLIN COVEY CO's quality score?
FC scores 48.647058823529406/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000886206, latest 10-Q filed 2026-04-08) · EODHD · as of 6/26/2026, 7:53:17 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-06-03
Procter Holly
President, Enterprise Division
Award3.38K
2026-06-03
Procter Holly
President, Enterprise Division
Tax989.00 @ $23.30$23.0K
2026-04-07
WHITMAN ROBERT A
Director
Gift26.3K
2026-01-29
WHITMAN ROBERT A
Director
Gift4.83K
2026-01-23
Phillips Nancy R
Director
Award5.78K
2026-01-23
RIVERA EFRAIN
Director
Award5.78K
2026-01-23
VAN BEVER DEREK C M
Director
Award5.78K
2026-01-23
MCNAMARA DONALD J
Director
Award5.78K
2026-01-23
WHITMAN ROBERT A
Director
Award5.78K

Earnings history

beat/miss · move
2026-04-01Miss -758.9% est▲ +2.28%8-K ↗
2026-01-07Miss -562.3% est▼ -0.89%8-K ↗
2025-11-05Miss -25.8% est▲ +5.11%8-K ↗
2025-07-02Miss -185.0% est▲ +0.25%8-K ↗
2025-04-02—▼ -0.39%8-K ↗
2025-01-08—▲ +0.17%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Franklin Covey (FC) Shares Cross Above 200 DMABullish
nasdaq.com· 2026-04-02
Franklin Covey Co. Q2 2026 Earnings Call SummaryBullish
finance.yahoo.com· 2026-04-02
Pre-Market Most Active for Apr 2, 2026 : TQQQ, SQQQ, TSLL, NVDA, IBIT, NIO, INTC, STLA, NKE, NOK, BP, FCXBullish
nasdaq.com· 2026-04-02
Franklin Covey reaffirms FY2026 guidance of $265M-$275M revenue and $28M-$33M adjusted EBITDA as multiyear mix reaches 62%Bullish
seekingalpha.com· 2026-04-02
Franklin Covey Q2 Earnings Call HighlightsBullish
finance.yahoo.com· 2026-04-01
After-Hours Earnings Report for April 1, 2026 : PENG, FC, BSETBullish
nasdaq.com· 2026-04-01

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score49 vs 67
Revenue growth-7.0% vs 7.1%
Net margin1.1% vs 10.5%
Return on equity4.6% vs 12.3%
P/E103.5 vs 25.5